Feb 24, 2026Polyphenol Stack Synergy: Quercetin, Resveratrol, Curcumin, and EGCG Combined EvidenceQuercetin, resveratrol, curcumin, and EGCG activate overlapping pathways — NRF2, SIRT1, AMPK, and NFkB inhibition. Stacking them is popular but evidence for synergistic human benefit is largely extrapolated from in vitro and animal models. This article assesses what stacking adds and what it does not.
Feb 20, 2026Osteoarthritis Symptom Load: Boswellia, Curcumin, and Ginger Trial EvidenceAdjunctive supplement evidence in osteoarthritis is strongest for modest pain and function support, with outcomes depending on extract quality, dose, and adherence.
Feb 4, 2026Anti-Inflammatory Supplement Comparison: Curcumin vs Boswellia vs Omega-3 vs GingerThe four most clinically studied anti-inflammatory supplements work through different molecular targets. Omega-3 resolves inflammation via resolvins and protectins. Curcumin inhibits NF-kB and COX-2. Boswellia inhibits 5-LOX. Ginger modulates multiple pathways. Combining agents may provide additive effects.
Jan 30, 2026Osteoarthritis and Supplements: Curcumin, Boswellia, Glucosamine — Evidence vs PlaceboOsteoarthritis supplement evidence is mixed. Curcumin and boswellia show consistent anti-inflammatory benefit. Glucosamine evidence is ambiguous — some trials show structural benefit, others don't. This article maps what evidence supports at realistic doses.
Jan 5, 2026Curcumin and Chronic Inflammation: Evidence, Dosing, and BioavailabilityCurcumin reduces inflammatory markers in multiple RCTs, but poor oral bioavailability limits standard formulations. Piperine co-dosing and liposomal forms substantially improve absorption.